Scholten L, van Huijgevoort NCM, van Hooft JE, et al. Pancreatic cystic neoplasms: different types, different management, new guidelines. Visc Med. 2018;34:173–7.

Article  PubMed  PubMed Central  Google Scholar 

Khoury RE, Kabir C, Maker VK, et al. What is the incidence of malignancy in resected intraductal papillary mucinous neoplasms? An analysis of over 100 US institutions in a single year. Ann Surg Oncol. 2018;25:1746–51.

Article  PubMed  Google Scholar 

Kromrey ML, Bulow R, Hubner J, et al. Prospective study on the incidence, prevalence, and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018;67:138–45.

Article  PubMed  Google Scholar 

van Huijgevoort NCM, Del Chiaro M, Wolfgang CL, et al. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol. 2019;16:676–89.

Article  PubMed  Google Scholar 

Fritz S, Fernandez-del Castillo C, Mino-Kenudson M, et al. Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann Surg. 2009;249:440–7.

Article  PubMed  Google Scholar 

Habib JR, Kinny-Koster B, Amini N, et al. Predictors, patterns, and timing of recurrence provide insight into the disease biology of invasive carcinomas arising in association with intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2022;26:2311–20.

Article  PubMed  Google Scholar 

Koh YX, Chok AY, Zheng HL, et al. Systematic review and meta-analysis comparing the surgical outcomes of invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2014;21:2782–800.

Article  PubMed  Google Scholar 

Patra KC, Bardeesy N, Mizukami Y. Diversity of precursor lesions for pancreatic cancer: the genetics and biology of intraductal papillary mucinous neoplasm. Clin Transl Gastroenterol. 2017;8:e86.

Article  PubMed  PubMed Central  Google Scholar 

Habib JR, Kinny-Koster B, Bou-Samra P, et al. Surgical decision-making in pancreatic ductal adenocarcinoma: modeling prognosis following pancreatectomy in the era of induction and neoadjuvant chemotherapy. Ann Surg. 2023;277:151–8.

Article  PubMed  Google Scholar 

Lucocq J, Halle-Smith J, Haugk B, et al. Long-term outcomes following resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm (A-IPMN) versus pancreatic ductal adenocarcinoma (PDAC): a propensity-score matched analysis. Ann Surg. 2024.

Daamen LA, Dorland G, Brada LJH, et al. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma. HPB Oxford. 2022;24:535–46.

Article  PubMed  Google Scholar 

Groot VP, Gemenetzis G, Blair AB, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019;269:1154–62.

Article  PubMed  Google Scholar 

Seelen LWF, Floortje van Oosten A, Brada LJH, et al. Early recurrence after resection of locally advanced pancreatic cancer following induction therapy: an international multicenter study. Ann Surg. 2023;278:118–26.

Article  PubMed  Google Scholar 

Aronsson L, Marinko S, Ansari D, et al. Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review. Ann Transl Med. 2019;7:689.

Article  PubMed  PubMed Central  Google Scholar 

Choi M, Chong JU, Hwang HK, et al. Role of postoperative adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas: a multicenter external validation. J Hepatobiliary Pancreat Sci. 2021;28:671–9.

Article  PubMed  Google Scholar 

Choi M, Wang SE, Park JS, et al. Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: an international multicenter cohort study. Int J Surg. 2023;109(10):2906–13. https://doi.org/10.1097/JS9.0000000000000537.

PubMed  PubMed Central  Google Scholar 

Marchegiani G, Andrianello S, Dal Borgo C, et al. Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data. HPB Oxford. 2019;21:596–603.

Article  PubMed  Google Scholar 

Rodrigues C, Hank T, Qadan M, et al. Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2020;20:722–8.

Article  PubMed  Google Scholar 

Turrini O, Waters JA, Schnelldorfer T, et al. Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy. HPB Oxford. 2010;12:447–55.

Article  PubMed  PubMed Central  Google Scholar 

Lucocq J, Hawkyard J, Haugk B, et al. Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study. Br J Surg. 2024;111(4):znae100. https://doi.org/10.1093/bjs/znae100.

Article  PubMed  Google Scholar 

Habib JR, Kinny-Koster B, Javed AA, et al. Impact of adjuvant chemotherapy on resected intraductal papillary mucinous neoplasm-derived pancreatic cancer: results from an international multicenter study. J Clin Oncol. 2024:JCO2302313.

Adsay V, Mino-Kenudson M, Furukawa T, et al. Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona Consensus Meeting. Ann Surg. 2016;263:162–77.

Article  PubMed  Google Scholar 

Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24:255–70.

Article  CAS  PubMed  Google Scholar 

Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297.

Article  PubMed  PubMed Central  Google Scholar 

Amin MB, Greene FL, Edge SB, et al. The Eighth-Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67:93–9.

Article  PubMed  Google Scholar 

Poruk KE, Lin JA, Cooper MA, et al. A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy. HPB Oxford. 2016;18:893–9.

Article  PubMed  PubMed Central  Google Scholar 

Yamamoto Y, Ikoma H, Morimura R, et al. Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis. Pancreatology. 2014;14:524–9.

Article  PubMed  Google Scholar 

Fogliati A, Zironda A, Fiorentini G, et al. Outcomes of neoadjuvant chemotherapy for invasive intraductal papillary mucinous neoplasm compared with de novo pancreatic adenocarcinoma. Ann Surg Oncol. 2024;31:2632–9.

Article  PubMed  PubMed Central  Google Scholar 

Lucocq J, Hawkyard J, Robertson FP, et al. Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study). Ann Surg. 2024;280(1):126–35. https://doi.org/10.1097/SLA.0000000000006144

Article  PubMed  Google Scholar 

Crippa S, Belfiori G, Bissolati M, et al. Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology. HPB Oxford. 2021;23:1666–73.

Article  PubMed  Google Scholar 

Horowitz M, Neeman E, Sharon E, et al. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol. 2015;12:213–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mansouri S, Daniel L, Amhis N, et al. Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma. Front Oncol. 2023;13:1071751.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murakawa M, Kawahara S, Takahashi D, et al. Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection. World J Surg Oncol. 2023;21:263.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki S, Shimoda M, Shimazaki J, et al. Predictive early recurrence factors of preoperative clinicophysiological findings in pancreatic cancer. Eur Surg Res. 2018;59:329–38.

Article  CAS